Parp inhibitors as maintenance treatment in platinum sensitive recurrent ovarian cancer: An updated meta-analysis of randomized clinical trials according to BRCA …
F Tomao, E Bardhi, A Di Pinto, CM Sassu… - Cancer Treatment …, 2019 - Elsevier
Objective This meta-analysis investigated the effectiveness of PARP inhibitors (PARPis) as
maintenance treatment in platinum sensitive recurrent ovarian cancer (ROC), stratifying …
maintenance treatment in platinum sensitive recurrent ovarian cancer (ROC), stratifying …
Modified fragility index and surgical complexity score are able to predict postoperative morbidity and mortality after cytoreductive surgery for advanced ovarian cancer
Objective The aim of this study was to assess the impact of surgical complexity on postoperative
complications and mortality, according to patient's frailty (mFI) following surgery for …
complications and mortality, according to patient's frailty (mFI) following surgery for …
[HTML][HTML] Survival nomograms after curative neoadjuvant chemotherapy and radical surgery for stage IB2-IIIB cervical cancer
C Marchetti, F De Felice, A Di Pinto… - Cancer Research and …, 2018 - ncbi.nlm.nih.gov
Purpose The purpose of this study was to develop nomograms for predicting the probability
of overall survival (OS) and progression-free survival (PFS) in locally advanced cervical …
of overall survival (OS) and progression-free survival (PFS) in locally advanced cervical …
Overcoming platinum resistance in ovarian cancer treatment: from clinical practice to emerging chemical therapies
…, A Romito, A Di Pinto, V Di Donato… - Expert opinion on …, 2017 - Taylor & Francis
Introduction: The objective of this review is to summarize results from clinical trials that tested
cytotoxic drugs and target strategies for the treatment of platinum resistant (PR) recurrent …
cytotoxic drugs and target strategies for the treatment of platinum resistant (PR) recurrent …
PD-L1 expression is associated with tumor infiltrating lymphocytes that predict response to NACT in squamous cell cervical cancer
…, A Di Pinto, L Musacchio, M Leopizzi, V Di Maio… - Virchows Archiv, 2021 - Springer
… and Di Pinto Anna collected and critically analyzed clinical data; Tomao Federica contributed
to statistical analysis; Musacchio Lucia collected clinical data; Leopizzi Martina and Di …
to statistical analysis; Musacchio Lucia collected clinical data; Leopizzi Martina and Di …
Prevention of recurrent lower urinary tract infections in postmenopausal women with genitourinary syndrome: outcome after 6 months of treatment with ospemifene
…, A Di Pinto, V Sciuga, P Faiano, C Di Tucci… - Gynecological …, 2018 - Taylor & Francis
Aim of this study was to evaluate the efficacy of ospemifene in the prevention of recurrent
lower urinary tract infections in postmenopausal women with vulvovaginal atrophy. The study …
lower urinary tract infections in postmenopausal women with vulvovaginal atrophy. The study …
[HTML][HTML] Fertility preservation in gynaecologic cancers
F De Felice, C Marchetti, A Di Pinto… - …, 2018 - ncbi.nlm.nih.gov
Due to substantial improvement in the diagnosis and treatment of gynaecologic cancers, a
better understanding of patient care needs to be revised. We reviewed the literature related to …
better understanding of patient care needs to be revised. We reviewed the literature related to …
[HTML][HTML] Hepatobiliary disease resection in patients with advanced epithelial ovarian cancer: prognostic role and optimal cytoreduction
…, A Giannini, O D'Oria, MC Schiavi, A Di Pinto… - Annals of Surgical …, 2021 - Springer
Objective The purpose of this study was to evaluate the feasibility and safety in terms of
prognostic significance and perioperative morbidity and mortality of cytoreduction in patients …
prognostic significance and perioperative morbidity and mortality of cytoreduction in patients …
Does hormone replacement therapy impact the prognosis in endometrial cancer survivors? A systematic review
…, D D'Aniello, L Musacchio, G Santangelo, A Di Pinto… - Oncology, 2020 - karger.com
Purpose: The objective of this study was to evaluate the impact of hormone replacement
therapy (HRT) on the prognosis in endometrial cancer (EC) survivors. Methods: The research …
therapy (HRT) on the prognosis in endometrial cancer (EC) survivors. Methods: The research …
A predictive score for secondary cytoreductive surgery in recurrent ovarian cancer (SeC-Score): a single-centre, controlled study for preoperative patient selection
…, G Scaletta, S Lopez, A Miranda, A Di Pinto… - Annals of surgical …, 2015 - Springer
Background The standard treatments of patients with platinum-sensitive recurrent ovarian
cancer (ROC) remains poorly defined. Chemotherapy (CT) and secondary cytoreductive …
cancer (ROC) remains poorly defined. Chemotherapy (CT) and secondary cytoreductive …